| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |